Paracrine Signaling Through MYCN Enhances Tumor-Vascular Interactions in Neuroblastoma
- 4 January 2012
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 4 (115) , 115ra3
Abstract
Neuroblastoma, a tumor of peripheral neural crest origin, numbers among the most common childhood cancers. Both amplification of the proto-oncogene MYCN and increased neoangiogenesis mark high-risk disease. Because angiogenesis is regulated by phosphatidylinositol 3-kinase (PI3K), we tested a clinical PI3K inhibitor, NVP-BEZ235, in MYCN-dependent neuroblastoma. NVP-BEZ235 decreased angiogenesis and improved survival in both primary human (highly pretreated recurrent MYCN-amplified orthotopic xenograft) and transgenic mouse models for MYCN-driven neuroblastoma. Using both gain- and loss-of-function approaches, we demonstrated that the antiangiogenic efficacy of NVP-BEZ235 depended critically on MYCN in vitro and in vivo. Thus, clinical PI3K/mammalian target of rapamycin inhibitors drove degradation of MYCN in tumor cells, with secondary paracrine blockade of angiogenesis. Our data demonstrated significantly improved survival in treated animals and suggest that NVP-BEZ235 should be tested in children with high-risk, MYCN-amplified neuroblastoma.Keywords
This publication has 35 references indexed in Scilit:
- Oncogenic PI3K deregulates transcription and translationNature Reviews Cancer, 2005
- Id2 Mediates Tumor Initiation, Proliferation, and Angiogenesis in Rb Mutant MiceMolecular and Cellular Biology, 2005
- Linking of N-Myc to Death Receptor Machinery in Neuroblastoma CellsJournal of Biological Chemistry, 2005
- Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7The EMBO Journal, 2004
- Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomasMedical and Pediatric Oncology, 2000
- MycN sensitizes neuroblastoma cells for drug-induced apoptosisOncogene, 1999
- Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction PathwayJournal of Biological Chemistry, 1998
- Targeted expression of MYCN causes neuroblastoma in transgenic miceThe EMBO Journal, 1997
- Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells.1996
- Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.Journal of Clinical Oncology, 1996